Ignite Creation Date:
2024-05-06 @ 12:37 AM
Last Modification Date:
2024-10-26 @ 10:52 AM
Study NCT ID:
NCT01610284
Status:
COMPLETED
Last Update Posted:
2020-08-25
First Post:
2012-05-11
Brief Title:
Phase III Study of BKM120Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-19
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-11
First Submit QC Date:
June 1 2012
Study First Post Date:
2012-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-24
Last Update Post Date:
2020-08-25
Last Update Post Date Type:
ACTUAL